134 related articles for article (PubMed ID: 12895686)
1. The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease.
Zangara A
Pharmacol Biochem Behav; 2003 Jun; 75(3):675-86. PubMed ID: 12895686
[TBL] [Abstract][Full Text] [Related]
2. Endophytic Fungal Community of
Cui L; Noushahi HA; Zhang Y; Liu J; Cosoveanu A; Liu Y; Yan L; Zhang J; Shu S
Molecules; 2021 Feb; 26(4):. PubMed ID: 33567664
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase-independent protective effects of huperzine A against iron overload-induced oxidative damage and aberrant iron metabolism signaling in rat cortical neurons.
Tao LX; Huang XT; Chen YT; Tang XC; Zhang HY
Acta Pharmacol Sin; 2016 Nov; 37(11):1391-1400. PubMed ID: 27498774
[TBL] [Abstract][Full Text] [Related]
4. Development of Neuroprotective Agents for the Treatment of Alzheimer's Disease using Conjugates of Serotonin with Sesquiterpene Lactones.
Neganova M; Liu J; Aleksandrova Y; Vasilieva N; Semakov A; Yandulova E; Sukocheva O; Balakin K; Klochkov S; Fan R
Curr Med Chem; 2024; 31(5):529-551. PubMed ID: 36437724
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype.
Pluta R; Ułamek-Kozioł M; Czuczwar SJ
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545070
[TBL] [Abstract][Full Text] [Related]
6. Herbal medicine in the treatment of Alzheimer's disease.
Akhondzadeh S; Abbasi SH
Am J Alzheimers Dis Other Demen; 2006; 21(2):113-8. PubMed ID: 16634467
[TBL] [Abstract][Full Text] [Related]
7.
Callizot N; Campanari ML; Rouvière L; Jacquemot G; Henriques A; Garayev E; Poindron P
Front Pharmacol; 2021; 12():681532. PubMed ID: 34526893
[No Abstract] [Full Text] [Related]
8. Validation of a microscale extraction and high-throughput UHPLC-QTOF-MS analysis method for huperzine A in Huperzia.
Cuthbertson D; Piljac-Žegarac J; Lange BM
Biomed Chromatogr; 2012 Oct; 26(10):1191-5. PubMed ID: 22275140
[TBL] [Abstract][Full Text] [Related]
9. Reference gene selection for real-time quantitative PCR assays in different tissues of
Fu Y; Niu F; Jia H; Wang Y; Guo B; Wei Y
Plant Direct; 2021 Nov; 5(11):e362. PubMed ID: 34849452
[No Abstract] [Full Text] [Related]
10. Machine learning identifies candidates for drug repurposing in Alzheimer's disease.
Rodriguez S; Hug C; Todorov P; Moret N; Boswell SA; Evans K; Zhou G; Johnson NT; Hyman BT; Sorger PK; Albers MW; Sokolov A
Nat Commun; 2021 Feb; 12(1):1033. PubMed ID: 33589615
[TBL] [Abstract][Full Text] [Related]
11. Research progress of plant-derived natural alkaloids in central nervous system diseases.
Zhang Q; Jiang Q; Sa K; Liang J; Sun D; Li H; Chen L
Phytother Res; 2023 Nov; 37(11):4885-4907. PubMed ID: 37455555
[TBL] [Abstract][Full Text] [Related]
12. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.
Wang R; Yan H; Tang XC
Acta Pharmacol Sin; 2006 Jan; 27(1):1-26. PubMed ID: 16364207
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease.
Wang R; Tang XC
Neurosignals; 2005; 14(1-2):71-82. PubMed ID: 15956816
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.
Xu SS; Gao ZX; Weng Z; Du ZM; Xu WA; Yang JS; Zhang ML; Tong ZH; Fang YS; Chai XS
Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):391-5. PubMed ID: 8701750
[TBL] [Abstract][Full Text] [Related]
15. Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies.
Ha GT; Wong RK; Zhang Y
Chem Biodivers; 2011 Jul; 8(7):1189-204. PubMed ID: 21766442
[TBL] [Abstract][Full Text] [Related]
16. A phase II trial of huperzine A in mild to moderate Alzheimer disease.
Rafii MS; Walsh S; Little JT; Behan K; Reynolds B; Ward C; Jin S; Thomas R; Aisen PS;
Neurology; 2011 Apr; 76(16):1389-94. PubMed ID: 21502597
[TBL] [Abstract][Full Text] [Related]
17. Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.
Yang G; Wang Y; Tian J; Liu JP
PLoS One; 2013; 8(9):e74916. PubMed ID: 24086396
[TBL] [Abstract][Full Text] [Related]
18. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial.
Hirayama S; Terasawa K; Rabeler R; Hirayama T; Inoue T; Tatsumi Y; Purpura M; Jäger R
J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():284-91. PubMed ID: 23495677
[TBL] [Abstract][Full Text] [Related]
19. Huperzine A for Alzheimer's disease.
Li J; Wu HM; Zhou RL; Liu GJ; Dong BR
Cochrane Database Syst Rev; 2008 Apr; (2):CD005592. PubMed ID: 18425924
[TBL] [Abstract][Full Text] [Related]
20. Treatment with Huperzine A improves cognition in vascular dementia patients.
Xu ZQ; Liang XM; Juan-Wu ; Zhang YF; Zhu CX; Jiang XJ
Cell Biochem Biophys; 2012 Jan; 62(1):55-8. PubMed ID: 21833673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
